Summary
Phoenix Molecular Designs
Founded in 2012
Description
Phoenix Molecular Designs is a Vancouver based biotechnology company founded by renowned Breast Cancer researcher Dr. Sandra Dunn, dedicated to developing an innovative targeted small molecule drugs to treat Triple Negative Breast Cancer. This therapy ...
Strengths
- Phoenix Molecular Designs has a strong market share in their industry
- Demonstrating revenue growth that is faster than the industry average
- The number of employees is growing faster than the industry average
- Since Phoenix Molecular Designs was founded, the company has grown faster than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
- Variance of revenue growth is more than the industry average
Annual Revenue
Phoenix Molecular Designs's annual revenue
$4557000
Based on Kona Equity data
-
Revenue per employee
$350538
-
Variance of revenue growth
0.87
-
Annual revenue growth since founding
$379750
-
Revenue growth rate from first known quarter to current
10.8%
Employee Count
13 employees
-
Employee growth rate from first known quarter to current
16.7%
Executives
G Score - 4
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G3 Revenue growth rate from the first known quarter to current is higher than the industry average.
- G4 Employee growth rate from the first known quarter to current is higher than the industry average.
- G6 Annual revenue growth since founding is higher than the industry average.
Location
Unlock unlimited leads
Similar Companies
WPD Pharmaceuticals
wpdpharmaceuticals.com- Founded in 2017
- Location: Vancouver, BC
- Annual Revenue: $2.5M
- Employees: 19
- WPD Pharmaceuticals is a clinical stage pharmaceutical company that focuses on developing biological and chemical molecules for targeted therapy in brain glioma and other central nervous system cancers. They specialize in oncology research and developm...
Oncolytics Biotech
oncolyticsbiotech.com- Founded in 1998
- Location: Calgary, AB
- Annual Revenue: $4.5M
- Employees: 26
- Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies.
Novelogics Biotechnology
novelogics.com- Founded in 2013
- Location: Coquitlam, British Columbia
- Annual Revenue: $4.1M
- Employees: 11
- Novelogics Biotechnology is a privately held, preclinical stage biotech company based in Vancouver, Canada. We are developing a novel monoclonal antibody immunotherapy drug for the treatment of cancer. Our drug targets immune suppressive proteins found...
Phoenix Biotechnology
phoenixbiotechnology.com- Location: San Antonio, TX
- Annual Revenue: $2.8M
- Employees: 8
- Phoenix Biotechnology is a Texas-based company specializing in the research and development of therapeutic agents and treatment regimens for cancer. They focus on developing safe and effective natural products for the treatment of human and animal dise...
Lindan Biotech
lindanbiotech.com- Founded in 1998
- Location: Winnipeg, Manitoba
- Annual Revenue: $4.3M
- Employees: 21
Bold Therapeutics
bold-therapeutics.com- Founded in 2018
- Location: Vancouver, BC
- Annual Revenue: $3.5M
- Employees: 14
- Bold Therapeutics is a clinical stage biotechnology company developing a first in class cancer therapy for the treatment of gastric, pancreatic, colorectal and other cancers in combination with existing anti cancer therapies.
Key Information
- Name: Phoenix Molecular Designs
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 283; 28
- NAICS: 3254; 32
See similar companies
-
By City Vancouver Small Biotechnology Company in Vancouver Mid-size Biotechnology Company in Vancouver Pharmaceuticals in Vancouver Small Pharmaceuticals in Vancouver Mid-size Pharmaceuticals in Vancouver
-
By State British Columbia Small companies in British Columbia Pharmaceuticals in British Columbia Small Pharmaceuticals in British Columbia Mid-size Pharmaceuticals in British Columbia Small Biotechnology Company in British Columbia Mid-size Biotechnology Company in British Columbia
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 4 Founded in 2012 SIC: 283 SIC: 28 NAICS: 3254 NAICS: 32 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Phoenix Molecular Designs's headquarters are located at 220-887 Great Northern Way Vancouver, British Columbia V5T 4T5.
Phoenix Molecular Designs's official website is phoenixmd.ca
Phoenix Molecular Designs's annual revenue is $4.6 M.
Phoenix Molecular Designs's SIC: 283; 28
Phoenix Molecular Designs's NAICS: 3254; 32.
Phoenix Molecular Designs has 13 employees
Phoenix Molecular Designs is in the industry of Pharmaceuticals.
